Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://tomaspopa303268.eedblog.com/39237025/retaglutide-a-promising-glp-1-receptor-agonist